Finance

Lists
Why is BILI up 6.55%?
Dive Deeper
BILI:NASDAQ
Bilibili Inc - ADR
$13.51
+6.55%
(+0.83) 1D
$13.55
+0.30% (+0.040)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BILI...
Open
$13.35
High
$13.74
Low
$13.34
Mkt. cap
5.68B
Avg. vol.
2.65M
Volume
5.62M
P/E ratio
26.68
52-wk high
$36.39
52-wk low
$12.64
EPS
$0.51
Beta
0.65
Shares outstanding
339.03M
No. of employees
8K
Open
$13.35
High
$13.74
Low
$13.34
Mkt. cap
5.68B
Avg. vol.
2.65M
Volume
5.62M
P/E ratio
26.68
52-wk high
$36.39
52-wk low
$12.64
EPS
$0.51
Beta
0.65
Shares outstanding
339.03M
No. of employees
8K
News stories
From web sources and news partners
About Bilibili Inc - ADR
CEORui Chen
Employees8.29K
FoundedDec 2013
Headquarters-
SectorInteractive media
Website-
Analyst ratings
Based on 6 analysts giving stock ratings to BILI in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BILI in the last 3 months.
Highest
Current $13.51
$34.00 (+151.67%)
Average
$27.30 (+102.07%)
Lowest
$21.00 (+55.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alex Liu
Bank of America Securities
Buy
Maintained
-
-
10/23/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
$21.00
+55.4%
10/16/2026
Brian Gong
Citi
Buy
Maintained
$26.50
+96.2%
10/13/2026
Jiong Shao
Barclays
Buy
Maintained
$34.00
+151.7%
08/31/2026
Saiyi He
CMB International Securities
Buy
Maintained
$28.00
+107.3%
08/28/2026
Yang Liu CFA
Morgan Stanley
Buy
Maintained
$27.00
+99.9%
08/27/2026
Lincoln Kong
Goldman Sachs
Buy
Maintained
$28.90
+113.9%
05/20/2026
Ellie Jiang
Macquarie
Buy
Maintained
$30.00
+122.1%
05/19/2026
Daniel Chen CFA
J.P. Morgan
Buy
Upgraded
$35.00
+159.1%
03/25/2026
Unknown Analyst
Aletheia Capital
Buy
Maintained
-
-
02/04/2026
Next call in 9 days
Thu, Nov 12, 7:00 AM
Fiscal period
Q3 2026
- / CN¥1.80
Revenue / Est. (CNY)
- / 8.26B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.69B
8.32B
7.47B
7.94B
Cost of goods sold
4.87B
5.24B
4.70B
4.98B
Cost of revenue
4.87B
5.24B
4.70B
4.98B
Research and development expenses
904.54M
921.06M
921.11M
1.01B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.56B
1.66B
1.69B
1.57B
Operating expense
2.46B
2.58B
2.61B
2.58B
Total operating expenses
7.33B
7.82B
7.31B
7.57B
Operating income
353.95M
503.88M
166.76M
372.87M
Other non operating income
112.32M
18.86M
-3.96M
99.05M
EBT including unusual items
454.64M
507.89M
221.28M
371.49M
EBT excluding unusual items
524.98M
560.77M
221.28M
445.60M
Income tax expense
-14.76M
-6.04M
19.29M
32.42M
Effective tax rate
-3.25%
-1.19%
8.72%
8.73%
Other operating expenses
-
-
-
-
Net income
470.23M
513.40M
209.78M
343.73M
Net profit margin
6.12%
6.17%
2.81%
4.33%
Earnings per share
1.75
1.94
1.31
1.58
Interest and investment income
122.53M
113.51M
172.38M
100.90M
Interest expense
-42.14M
-40.36M
-39.34M
-37.55M
Net interest expenses
80.39M
73.15M
133.05M
63.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
935.63M
1.01B
673.29M
879.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps